{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:59:19Z","timestamp":1788919159403,"version":"build-2803163510"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Adenosine 5'-triphosphate (ATP), other nucleotides, and the nucleoside analogue, adenosine, all have the capacity to modulate cellular signaling pathways. The cellular processes linked to extracellular purinergic signaling are crucial in the initiation, evolution, and resolution of inflammation. Injured or dying cells in the pancreatobiliary tract secrete or release ATP, which results in sustained purinergic signaling mediated through ATP type-2 purinergic receptors (P2R). This process can result in chronic inflammation, fibrosis, and tumor development. In contrast, signaling <jats:italic>via<\/jats:italic> the extracellular nucleoside derivative adenosine <jats:italic>via<\/jats:italic> type-1 purinergic receptors (P1R) is largely anti-inflammatory, promoting healing. Failure to resolve inflammation, as in the context of primary sclerosing cholangitis or chronic pancreatitis, is a risk factor for parenchymal and end-organ scarring with the associated risk of pancreatobiliary malignancies. Emerging immunotherapeutic strategies suggest that targeting purinergic and adenosinergic signaling can impact the growth and invasive properties of cancer cells, potentiate anti-tumor immunity, and also block angiogenesis. In this review, we dissect out implications of disordered purinergic responses in scar formation, end-organ injury, and in tumor development. We conclude by addressing promising opportunities for modulation of purinergic\/adenosinergic signaling in the prevention and treatment of pancreatobiliary diseases, inclusive of cancer.<\/jats:p>","DOI":"10.3389\/fphys.2022.849258","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:20:52Z","timestamp":1647242452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Erika Y.","family":"Faraoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger K.","family":"Eltzschig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Bailey-Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","article-title":"Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs","volume":"19","author":"Allard","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","article-title":"Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors","volume":"11","author":"Alnouri","year":"2015","journal-title":"Purinergic Signal"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/FPC.0000000000000086","article-title":"PharmGKB summary: gemcitabine pathway","volume":"24","author":"Alvarellos","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2015.10","article-title":"Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations","volume":"11","author":"Antonioli","year":"2015","journal-title":"Nat. Rev. Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0234038","DOI":"10.1371\/journal.pone.0234038","article-title":"Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis","volume":"15","author":"Baeza-Raja","year":"2020","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0014-5793(03)00172-8","article-title":"Specific detection of non-functional human P2X(7) receptors in HEK293 cells and B-lymphocytes","volume":"538","author":"Barden","year":"2003","journal-title":"FEBS Lett"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.it.2012.02.009","article-title":"CD73: a potent suppressor of antitumor immune responses","volume":"33","author":"Beavis","year":"2012","journal-title":"Trends Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J. Autoimmun"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1573399815666190115145702","article-title":"Type-3c diabetes mellitus, diabetes of exocrine pancreas - an update","volume":"15","author":"Bhattamisra","year":"2019","journal-title":"Curr. Diabetes Rev"},{"key":"ref12","year":"2021"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","article-title":"Adenosine metabolism: emerging concepts for cancer therapy","volume":"36","author":"Boison","year":"2019","journal-title":"Cancer Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/JOE-11-0434","article-title":"Purinergic signalling in the pancreas in health and disease","volume":"213","author":"Burnstock","year":"2012","journal-title":"J. Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11302-013-9398-8","article-title":"Purinergic signalling in the liver in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.3748\/wjg.v27.i40.6844","article-title":"Role of human nucleoside transporters in pancreatic cancer and chemoresistance","volume":"27","author":"Carter","year":"2021","journal-title":"World J. Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1111\/jcmm.15500","article-title":"CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat. Commun"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MPA.0b013e318271bb4b","article-title":"Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor","volume":"42","author":"Choi","year":"2013","journal-title":"Pancreas"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.smim.2015.03.007","article-title":"Neutrophils and inflammatory resolution in the mucosa","volume":"27","author":"Colgan","year":"2015","journal-title":"Semin. Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pan.2021.01.006","article-title":"Biomarkers of chronic pancreatitis: a systematic literature review","volume":"21","author":"Cruz-Monserrate","year":"2021","journal-title":"Pancreatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv. Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic signaling, DAMPs, and inflammation","volume":"318","author":"Di Virgilio","year":"2020","journal-title":"Am. J. Phys. Cell Physiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"","journal-title":"Nat. Rev. Cancer"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tcb.2018.01.005","article-title":"The elusive P2X7 macropore","volume":"28","author":"Di Virgilio","year":"","journal-title":"Trends Cell Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"G463","DOI":"10.1152\/ajpgi.00395.2018","article-title":"Extracellular release of ATP promotes systemic inflammation during acute pancreatitis","volume":"317","author":"Dixit","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20050177","article-title":"HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia","volume":"202","author":"Eltzschig","year":"2005","journal-title":"J. Exp. Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1007\/s00018-021-03761-6","article-title":"Structure and function of adenosine receptor heteromers","volume":"78","author":"Franco","year":"2021","journal-title":"Cell. Mol. Life Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/ijc.30380","article-title":"Targeting of the P2X7 receptor in pancreatic cancer and stellate cells","volume":"139","author":"Giannuzzo","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jhep.2014.06.036","article-title":"Functional crosstalk between the adenosine transporter CNT3 and purinergic receptors in the biliary epithelia","volume":"61","author":"Godoy","year":"2014","journal-title":"J. Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.24966\/ACIM-7562\/100180","article-title":"Reduced proportion of CD39+ treg cells correlates with the development of primary biliary cholangitis in patients and a murine model","volume":"7","author":"Gong","year":"2021","journal-title":"J. Alter. Complement. Integr. Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2017.03.026","article-title":"Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine\/paracrine signaling of the adenosine A3 receptor","volume":"397","author":"Gorzalczany","year":"2017","journal-title":"Cancer Lett"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3748\/wjg.v19.i31.5029","article-title":"Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed","volume":"19","author":"Guarino","year":"2013","journal-title":"World J. Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000149793","article-title":"Purinergic receptors and calcium signalling in human pancreatic duct cell lines","volume":"22","author":"Hansen","year":"2008","journal-title":"Cell. Physiol. Biochem"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"E3786","DOI":"10.1073\/pnas.1701379114","article-title":"On the permeation of large organic cations through the pore of ATP-gated P2X receptors","volume":"114","author":"Harkat","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.14309\/ajg.0000000000000421","article-title":"Chronic pancreatitis: managing a difficult disease","volume":"115","author":"Hart","year":"2020","journal-title":"Am. J. Gastroenterol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.4049\/jimmunol.0901851","article-title":"SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning","volume":"184","author":"Hart","year":"2010","journal-title":"J. Immunol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/jcp.24568","article-title":"Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells","volume":"229","author":"Hassanian","year":"2014","journal-title":"J. Cell. Physiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00109-014-1189-3","article-title":"Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1\u03b1-dependent and extracellular adenosine-mediated tumor protection","volume":"92","author":"Hatfield","year":"2014","journal-title":"J. Mol. Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"277ra30","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1172\/JCI137554","article-title":"Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy","volume":"130","author":"Hatfield","year":"2020","journal-title":"J. Clin. Invest"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e1208875","DOI":"10.1080\/2162402X.2016.1208875","article-title":"Targeting CD73 in the tumor microenvironment with MEDI9447","volume":"5","author":"Hay","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.3390\/ijms20215329","article-title":"Expression of adenosine receptors in rodent pancreas","volume":"20","author":"Hayashi","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00424-016-1806-9","article-title":"The adenosine A2B receptor is involved in anion secretion in human pancreatic duct Capan-1 epithelial cells","volume":"468","author":"Hayashi","year":"2016","journal-title":"Pflugers Arch"},{"key":"ref52","first-page":"1181","article-title":"CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma","volume":"7","author":"Hayes","year":"2015","journal-title":"Am. J. Transl. Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1158\/0008-5472.CAN-15-2268","article-title":"p120 catenin suppresses basal epithelial cell extrusion in invasive pancreatic neoplasia","volume":"76","author":"Hendley","year":"2016","journal-title":"Cancer Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-18-2297","article-title":"Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis","volume":"25","author":"Hu","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4254\/wjh.v9.i36.1378","article-title":"Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma","volume":"9","author":"Ide","year":"2017","journal-title":"World J. Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e037267","DOI":"10.1136\/bmjopen-2020-037267","article-title":"New onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES trial): protocol of a prospective, multicentre observational trial","volume":"10","author":"Ill\u00e9s","year":"2020","journal-title":"BMJ Open"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4049\/jimmunol.1700850","article-title":"A","volume":"201","author":"Kjaergaard","year":"2018","journal-title":"J. Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"G223","DOI":"10.1152\/ajpgi.00259.2006","article-title":"Upregulation of CD39\/NTPDases and P2 receptors in human pancreatic disease","volume":"292","author":"K\u00fcnzli","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.gastro.2007.10.030","article-title":"Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice","volume":"134","author":"K\u00fcnzli","year":"2008","journal-title":"Gastroenterology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3389\/fphar.2020.00793","article-title":"P2X7 in cancer: from molecular mechanisms to therapeutics","volume":"11","author":"Lara","year":"2020","journal-title":"Front. Pharmacol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/2159-8290.CD-15-0822","article-title":"Hif1a deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia","volume":"6","author":"Lee","year":"2016","journal-title":"Cancer Discov"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.21873\/anticanres.11725","article-title":"Inhibitory effects of ATP and adenosine on cholangiocarcinoma cell proliferation and motility","volume":"37","author":"Lertsuwan","year":"2017","journal-title":"Anticancer Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"604944","DOI":"10.3389\/fimmu.2020.604944","article-title":"Adenosine at the interphase of hypoxia and inflammation in lung injury","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","article-title":"Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"114417","DOI":"10.1016\/j.bcp.2021.114417","article-title":"Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut","volume":"187","author":"Longhi","year":"2021","journal-title":"Biochem. Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00109-017-1545-1","article-title":"Purinergic signaling during intestinal inflammation","volume":"95","author":"Longhi","year":"2017","journal-title":"J. Mol. Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12882-019-1540-6","article-title":"TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes","volume":"20","author":"Magistroni","year":"2019","journal-title":"BMC Nephrol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(16)00097-0","article-title":"Chronic pancreatitis","volume":"387","author":"Majumder","year":"2016","journal-title":"Lancet"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.4161\/cc.8.22.10026","article-title":"Chemotherapy induces ATP release from tumor cells","volume":"8","author":"Martins","year":"2009","journal-title":"Cell Cycle"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat. Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1951.e1","DOI":"10.1053\/j.gastro.2018.11.081","article-title":"Genetics, cell biology, and pathophysiology of pancreatitis","volume":"156","author":"Mayerle","year":"2019","journal-title":"Gastroenterology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.130.3370.245","article-title":"Organic compound synthesis on the primitive earth","volume":"130","author":"Miller","year":"1959","journal-title":"Science"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","article-title":"Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor","volume":"74","author":"Mittal","year":"2014","journal-title":"Cancer Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat. Rev. Immunol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.bjc.6603559","article-title":"Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells","volume":"96","author":"Nakano","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12915-018-0491-x","article-title":"Cross-communication between G i and G s in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain","volume":"16","author":"Navarro","year":"2018","journal-title":"BMC Biol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.pharmtox.40.1.563","article-title":"Pharmacology of cloned P2X receptors","volume":"40","author":"North","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"8781","DOI":"10.3390\/ijms21228781","article-title":"Purinergic signaling in pancreas-from physiology to therapeutic strategies in pancreatic cancer","volume":"21","author":"Novak","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fphar.2018.00606","article-title":"Emerging roles of nucleoside transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/cells10010189","article-title":"P2X7 variants in Oncogenesis","volume":"10","author":"Pegoraro","year":"2021","journal-title":"Cell"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/hep4.1084","article-title":"The ectonucleotidase ENTPD1\/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis","volume":"1","author":"Peng","year":"2017","journal-title":"Hepatol. Commun"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.4049\/jimmunol.178.8.4820","article-title":"Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D","volume":"178","author":"Peter","year":"2007","journal-title":"J. Immunol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"E2156","DOI":"10.1073\/pnas.1610414114","article-title":"Localization of the gate and selectivity filter of the full-length P2X7 receptor","volume":"114","author":"Pippel","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.celrep.2018.02.006","article-title":"P2RY1\/ALK3-expressing cells within the adult human exocrine pancreas are BMP-7 expandable and exhibit progenitor-like characteristics","volume":"22","author":"Qadir","year":"2018","journal-title":"Cell Rep"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2013.12.007","article-title":"Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions","volume":"146","author":"Rhim","year":"2014","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"795.e12","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.lfs.2011.08.007","article-title":"Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge","volume":"89","author":"Rose","year":"2011","journal-title":"Life Sci"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11302-019-09664-3","article-title":"Selective deletion of ENTPD1\/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis","volume":"15","author":"Rothweiler","year":"2019","journal-title":"Purinergic Signal"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1053\/j.gastro.2019.01.268","article-title":"Early intra-acinar events in pathogenesis of pancreatitis","volume":"156","author":"Saluja","year":"2019","journal-title":"Gastroenterology"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1053\/j.gastro.2019.03.050","article-title":"Pancreatitis and pancreatic cancer","volume":"156","author":"Saluja","year":"2019","journal-title":"Gastroenterology"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"154731","DOI":"10.1016\/j.metabol.2021.154731","article-title":"Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism","volume":"118","author":"Sandhu","year":"2021","journal-title":"Metabolism"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/156800911793743600","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)","volume":"11","author":"Santini","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00262-018-2290-1","article-title":"CD73 expression in normal and pathological human hepatobiliopancreatic tissues","volume":"68","author":"Sciarra","year":"2019","journal-title":"Cancer Immunol. Immunother"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"704.e10","DOI":"10.1053\/j.gastro.2017.10.018","article-title":"Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice","volume":"154","author":"Sendler","year":"2018","journal-title":"Gastroenterology"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10565-016-9331-3","article-title":"Extracellular ATP protects pancreatic duct epithelial cells from alcohol-induced damage through P2Y1 receptor-cAMP signal pathway","volume":"32","author":"Seo","year":"2016","journal-title":"Cell Biol. Toxicol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1744946","DOI":"10.1080\/2162402X.2020.1744946","article-title":"Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses","volume":"9","author":"Shevchenko","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.29.470415","article-title":"Pancreatic cancer ductal cell of origin drives CD73-dependent generation of immunosuppressive adenosine","author":"Singh","year":"2021","journal-title":"bioRxiv"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: a review","volume":"322","author":"Singh","year":"2019","journal-title":"JAMA"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.it.2008.12.002","article-title":"T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response","volume":"30","author":"Sitkovsky","year":"2009","journal-title":"Trends Immunol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1021\/acs.biochem.7b00339","article-title":"Human concentrative nucleoside transporter 3 (hCNT3, SLC28A3) forms a cyclic homotrimer","volume":"56","author":"Stecula","year":"2017","journal-title":"Biochemistry"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","article-title":"CD39\/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice","volume":"139","author":"Sun","year":"2010","journal-title":"Gastroenterology"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J. Clin. Invest"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"254640","DOI":"10.1155\/2014\/254640","article-title":"Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis","volume":"2014","author":"Vieira","year":"2014","journal-title":"Mediat. Inflamm"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3389\/fimmu.2020.01882","article-title":"Control of gut inflammation by modulation of purinergic signaling","volume":"11","author":"Vuerich","year":"2020","journal-title":"Front. Immunol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"636678","DOI":"10.3389\/fmolb.2021.636678","article-title":"Enhancing extracellular adenosine levels restores barrier function in acute lung injury through expression of focal adhesion proteins","volume":"8","author":"Wang","year":"","journal-title":"Front. Mol. Biosci"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41467-020-20447-y","article-title":"Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis","volume":"12","author":"Wang","year":"","journal-title":"Nat. Commun"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"549179","DOI":"10.3389\/fimmu.2020.549179","article-title":"P2RX1-involved glycolytic metabolism supports neutrophil activation in acute pancreatitis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"570276","DOI":"10.3389\/fphys.2020.570276","article-title":"Pathological mechanisms in diabetes of the exocrine pancreas: what's known and what's to know","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Physiol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2337\/db19-0687","article-title":"Secretory functions of macrophages in the human pancreatic islet are regulated by endogenous purinergic signaling","volume":"69","author":"Weitz","year":"2020","journal-title":"Diabetes"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/bj1950389","article-title":"Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes","volume":"195","author":"Wiginton","year":"1981","journal-title":"Biochem. J"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2468-1253(16)30004-8","article-title":"Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies","volume":"1","author":"Xiao","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.7150\/jca.51038","article-title":"High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma","volume":"12","author":"Xu","year":"2021","journal-title":"J. Cancer"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","article-title":"Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses","volume":"30","author":"Young","year":"2016","journal-title":"Cancer Cell"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2020.05.010","article-title":"Transcription factor HIF1\u03b1 promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19\/microRNA-612\/Bcl-2 axis","volume":"224","author":"Yu","year":"2020","journal-title":"Transl. Res"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00249-016-1171-9","article-title":"In silico analysis of the transportome in human pancreatic ductal adenocarcinoma","volume":"45","author":"Zaccagnino","year":"2016","journal-title":"Eur. Biophys. J"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.pan.2021.03.018","article-title":"Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival","volume":"21","author":"Zhao","year":"2021","journal-title":"Pancreatology"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.849258\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:20:56Z","timestamp":1647242456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.849258\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":125,"alternative-id":["10.3389\/fphys.2022.849258"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.849258","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"article-number":"849258"}}